Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 November 2008, Vol. 112, No. 10, pp. 3995-4002.
Prepublished online as a Blood First Edition Paper on August 28, 2008; DOI 10.1182/blood-2008-05-155960.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Appendix and Table
Right arrow All Versions of this Article:
blood-2008-05-155960v1
112/10/3995    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartman, M. T.
Right arrow Articles by Murphy, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartman, M. T.
Right arrow Articles by Murphy, E. L.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Immunobiology
Right arrow Clinical Trials and Observations
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CLINICAL TRIALS AND OBSERVATIONS

Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection

Melissa T. Bartman1,2, Zhanna Kaidarova2, Dale Hirschkorn2, Ronald A. Sacher3, Joy Fridey4, George Garratty5, Joan Gibble6, James W. Smith7, Bruce Newman8, Anthony E. Yeo2, Edward L. Murphy2,9, for the HTLV Outcomes Study (HOST) investigators

1 School of Public Health, University of California, Berkeley; 2 Blood Systems Research Institute, San Francisco, CA; 3 Hoxworth Blood Center, University of Cincinnati, OH; 4 City of Hope Medical Center, Duarte, CA; 5 American Red Cross Blood Services, Southern California Region, Pomona; 6 American Red Cross Blood Services, Greater Chesapeake and Potomac Region, Baltimore, MD; 7 Sylvan N. Goldman Center, Oklahoma Blood Institute, Oklahoma City; 8 American Red Cross Blood Services, Southeastern Michigan Region, Detroit; and 9 University of California at San Francisco

Human T-lymphotropic viruses types I and II (HTLV-I and HTLV-II) cause chronic infections of T lymphocytes that may lead to leukemia and myelopathy. However, their long-term effects on blood counts and hematopoiesis are poorly understood. We followed 151 HTLV-I–seropositive, 387 HTLV-II–seropositive, and 799 HTLV-seronegative former blood donors from 5 U.S. blood centers for a median of 14.0 years. Complete blood counts were performed every 2 years. Multivariable repeated measures analyses were conducted to evaluate the independent effect of HTLV infection and potential confounders on 9 hematologic measurements. Participants with HTLV-II had significant (P < .05) increases in their adjusted lymphocyte counts (+126 cells/mm3; approximately +7%), hemoglobin (+2 g/L [+0.2 g/dL]) and mean corpuscular volume (MCV; 1.0 fL) compared with seronegative participants. Participants with HTLV-I and HTLV-II had higher adjusted platelet counts (+16 544 and +21 657 cells/mm3; P < .05) than seronegatives. Among all participants, time led to decreases in platelet count and lymphocyte counts, and to increases in MCV and monocytes. Sex, race, smoking, and alcohol consumption all had significant effects on blood counts. The HTLV-II effect on lymphocytes is novel and may be related to viral transactivation or immune response. HTLV-I and HTLV-II associations with higher platelet counts suggest viral effects on hematopoietic growth factors or cytokines.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Hematologic hints of HTLV-2 in US blood donors
Mark A. Beilke
Blood 2008 112: 3919-3920. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
G. Besson and M. Kazanji
One-Step, Multiplex, Real-Time PCR Assay with Molecular Beacon Probes for Simultaneous Detection, Differentiation, and Quantification of Human T-Cell Leukemia Virus Types 1, 2, and 3
J. Clin. Microbiol., April 1, 2009; 47(4): 1129 - 1135.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020